Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
20 enrolled 12 charts
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
23 enrolled 11 charts
A Study to Assess DCC-2618 and Sunitinib in Patients With Advanced GIST After Treatment With Imatinib
Phase 2 Completed
108 enrolled 11 charts
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Phase 2 Completed
59 enrolled 11 charts
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Phase 2 Completed
18 enrolled 12 charts
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
Completed
460 enrolled 7 charts
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Phase 2/3 Completed
159 enrolled 17 charts
Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
Phase 1/2 Completed
12 enrolled 9 charts
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Phase 1/2 Completed
47 enrolled 36 charts
Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
Phase 2/3 Completed
400 enrolled 15 charts
RADIOSARP
Phase 1 Completed
41 enrolled 15 charts
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
Phase 2 Completed
19 enrolled 11 charts
Lymphodepletion Plus Adoptive Cell Therapy With High Dose IL-2 in Adolescent and Young Adult Patients With Soft Tissue Sarcoma
Phase 1 Completed
9 enrolled 10 charts
GEMMK
Phase 1/2 Completed
25 enrolled 15 charts
Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer
Phase NA Completed
68 enrolled 20 charts
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
Phase 2 Completed
34 enrolled 22 charts
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Phase 3 Completed
642 enrolled 11 charts
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Phase 1 Completed
12 enrolled 12 charts
Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
Phase 4 Completed
34 enrolled 11 charts
TARMIC
Phase 1/2 Completed
50 enrolled 15 charts
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
Phase 2 Completed
36 enrolled 13 charts
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer
Phase 2 Completed
98 enrolled 12 charts
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
Phase 2 Completed
34 enrolled 14 charts
PEMBROSARC
Phase 2 Completed
129 enrolled 17 charts
METABONE
Completed
545 enrolled 7 charts
Proton Radiation for Chordomas and Chondrosarcomas
Phase NA Completed
54 enrolled 11 charts
LEADER
Phase 1/2 Completed
30 enrolled 9 charts
LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)
Phase 2 Completed
6 enrolled 17 charts
Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall
Phase NA Completed
35 enrolled 15 charts
Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma
Phase 2 Completed
21 enrolled 12 charts
Molecular-Guided Therapy for Childhood Cancer
Phase NA Completed
186 enrolled 12 charts
A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures
Phase 4 Completed
132 enrolled 9 charts
Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
Phase 1 Completed
39 enrolled 27 charts
EPIBONE
Phase NA Completed
34 enrolled 11 charts
METASARC
Completed
2,165 enrolled 4 charts
TRAMUNE
Phase 1 Completed
40 enrolled 23 charts
TOMOREP
Phase NA Completed
48 enrolled 15 charts
Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
Phase 2 Completed
29 enrolled 13 charts
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
Phase 2 Completed
57 enrolled 14 charts
CYCLIGIST
Phase 2 Completed
29 enrolled 8 charts
Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab
Phase 2 Completed
35 enrolled 13 charts
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
Phase NA Completed
163 enrolled 2 charts
Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma
Phase 2 Completed
30 enrolled 12 charts
BEB
Phase 2 Completed
108 enrolled 15 charts
P204
Phase 2 Completed
111 enrolled 22 charts
PCI-24781 in Combination With Doxorubicin to Treat Sarcoma
Phase 1/2 Completed
20 enrolled 10 charts
ANNOUNCE
Phase 3 Completed
509 enrolled 23 charts
Real-world Study of Dedifferentiated Liposarcoma Patients in China
Completed
1,390 enrolled 14 charts
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Phase 2 Completed
15 enrolled 15 charts
Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas
Phase NA Completed
70 enrolled 9 charts